Upon closing of the proposed transaction, Pulmatrix stockholders are expected to own approximately 3.6% of the combined company. If you are a Pulmatrix shareholder, click here to learn more about your ...
Louis jury cleared the company regarding a claim that the company hid risks that its premature-infant formula can cause a bowel disease that severely sickened a baby boy. Charter Communications (CHTR) ...